Pharmacokinetics of phenobarbital following single and repeated doses. 1979

C T Viswanathan, and H E Booker, and P G Welling

Serum levels of phenobarbital, and also urinary excretion of phenobarbital and p-hydroxyphenobarbital, were examined after single and repeated oral doses of phenobarbital to three male subjects. Serum levels of phenobarbital at steady state were approximately ten times as high as those after a single dose. The overall elimination rate constant for loss of phenobarbital from serum, Kel, was significantly reduced after repeated doses, and Cmax infinity values calculated from single-dose data poorly predicted observed Cmax infinity values. Five-day urinary excretion of phenobarbital and p-hydroxyphenobarbital accounted for 16 and 21 per cent, respectively, of the initial dose. Due to extensive drug accumulation, 83 per cent of the final dose was excreted in five-day urine as phenobarbital and 85 per cent, as p-hydroxyphenobarbital. Comparison of plasma and renal clearances indicated that the rate of phenobarbital metabolism was reduced owing to repeated dosing, while the rate of urinary excretion of parent drug was unchanged.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006900 Hydroxylation Placing of a hydroxyl group on a compound in a position where one did not exist before. (Stedman, 26th ed) Hydroxylations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

C T Viswanathan, and H E Booker, and P G Welling
September 2022, Journal of veterinary pharmacology and therapeutics,
C T Viswanathan, and H E Booker, and P G Welling
November 1980, European journal of clinical pharmacology,
C T Viswanathan, and H E Booker, and P G Welling
June 1999, International journal of clinical pharmacology and therapeutics,
C T Viswanathan, and H E Booker, and P G Welling
April 1987, American journal of veterinary research,
C T Viswanathan, and H E Booker, and P G Welling
August 1990, International journal of clinical pharmacology, therapy, and toxicology,
C T Viswanathan, and H E Booker, and P G Welling
January 1985, Journal of clinical pharmacology,
C T Viswanathan, and H E Booker, and P G Welling
January 1980, European journal of drug metabolism and pharmacokinetics,
C T Viswanathan, and H E Booker, and P G Welling
January 1983, Scandinavian journal of infectious diseases,
C T Viswanathan, and H E Booker, and P G Welling
July 1992, Biopharmaceutics & drug disposition,
Copied contents to your clipboard!